Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer

Conclusion: The methylation status of T-cadherin promoter was strongly associated with CRC risk. However, T-cadherin promoter methylation may have a limited prognostic value for CRC patients.

Source: Cancer Genomics and Proteomics - June 24, 2017 Category: Cancer & Oncology Authors: DUAN, B.-S., XIE, L.-F., WANG, Y. Tags: Article Source Type: research